Metoprolol Succinate

琥珀酸美托洛尔

Report date: 2026/05/20 20:02:01

Base Information

Drug NameMetoprolol Succinate
Drug Alias NameToprol XLSpesicor Dos
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-1 adrenergic receptor antagonists
TargetsBeta-1 adrenergic receptor
Therapy Area/IndicationsNeurocirculatory AstheniaFastingHyperthyroidism +[16] 
Global Approved IndicationsNeurocirculatory AstheniaHyperthyroidismHypertension +[6] 
Approved Indications in ChinaNeurocirculatory AstheniaHyperthyroidismHypertension +[6] 
Original Approved Country/TerritoryMainland China
Original Approved Date1985/01/01
Country/TerritoryUnited StatesPolandBrazil +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAralez Pharma
China Registration ClassN/A

Develop Information

Active CompaniesMelinta Therapeutics LLCAstrazeneca Pharmaceutical Co LtdNanfang Hospital Of Southern Medical University +[4] 
Inactive CompaniesUniversity of Sao PauloWake Forest University Health SciencesIpca Laboratories Ltd +[8] 
Active IndicationsNeurocirculatory AstheniaHyperthyroidismHypertension +[8] 
Inactive IndicationsFastingMitral Valve InsufficiencyHeart Valve Diseases +[8] 

Other Information

ATC CodeC07AB02
Related LinksWikipediaDrugBankKEGG